chrysophanic acid has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, R; Jiang, W; Li, L; Liu, X; Song, D; Xu, R; Zhang, C; Zhang, X | 1 |
| Duan, Y; Fang, Y; Gao, L; Li, J; Luo, Y; Zhao, H; Zhao, Y | 1 |
2 other study(ies) available for chrysophanic acid and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Chrysophanol facilitates long-term neurological recovery through limiting microglia-mediated neuroinflammation after ischemic stroke in mice.
Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Cytokines; Infarction, Middle Cerebral Artery; Inflammation; Interleukin-6; Ischemic Stroke; Mice; Mice, Inbred C57BL; Microglia; Neuroinflammatory Diseases; Stroke | 2022 |
Neuroprotective effects of Chrysophanol against inflammation in middle cerebral artery occlusion mice.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Behavior, Animal; Brain; Brain Ischemia; Encephalitis; Infarction, Middle Cerebral Artery; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Reperfusion Injury; Rotarod Performance Test; Survival Analysis; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2016 |